1. RvD1n-3 DPA Downregulates the Transcription of Pro-Inflammatory Genes in Oral Epithelial Cells and Reverses Nuclear Translocation of Transcription Factor p65 after TNF-α Stimulation
- Author
-
Maria G. Balta, Olav Schreurs, Rashi Halder, Thomas M. Küntziger, Frank Saetre, Inger Johanne S. Blix, Espen S. Baekkevold, Enrico Glaab, Karl Schenck, and Luxembourg Centre for Systems Biomedicine (LCSB): Biomedical Data Science (Glaab Group) [research center]
- Subjects
Multidisciplinaire, généralités & autres [D99] [Sciences de la santé humaine] ,resolvin ,specialized pro-resolving mediators ,oral epithelium ,gingival ,oral inflammation ,periodontitis ,p65 ,NF-κB ,Active Transport, Cell Nucleus ,Multidisciplinary, general & others [F99] [Life sciences] ,Catalysis ,Inorganic Chemistry ,Multidisciplinaire, généralités & autres [F99] [Sciences du vivant] ,Humans ,Physical and Theoretical Chemistry ,Molecular Biology ,Spectroscopy ,Multidisciplinary, general & others [D99] [Human health sciences] ,Tumor Necrosis Factor-alpha/metabolism ,Organic Chemistry ,General Medicine ,Inflammation/genetics/metabolism ,Epithelial Cells/metabolism ,Computer Science Applications ,NF-kappa B/metabolism ,Transcription Factor RelA/genetics/metabolism - Abstract
Specialized pro-resolving mediators (SPMs) are multifunctional lipid mediators that participate in the resolution of inflammation. We have recently described that oral epithelial cells (OECs) express receptors of the SPM resolvin RvD1n-3 DPA and that cultured OECs respond to RvD1n-3 DPA addition by intracellular calcium release, nuclear receptor translocation and transcription of genes coding for antimicrobial peptides. The aim of the present study was to assess the functional outcome of RvD1n-3 DPA–signaling in OECs under inflammatory conditions. To this end, we performed transcriptomic analyses of TNF-α-stimulated cells that were subsequently treated with RvD1n-3 DPA and found significant downregulation of pro-inflammatory nuclear factor kappa B (NF-κB) target genes. Further bioinformatics analyses showed that RvD1n-3 DPA inhibited the expression of several genes involved in the NF-κB activation pathway. Confocal microscopy revealed that addition of RvD1n-3 DPA to OECs reversed TNF-α-induced nuclear translocation of NF-κB p65. Co-treatment of the cells with the exportin 1 inhibitor leptomycin B indicated that RvD1n-3 DPA increases nuclear export of p65. Taken together, our observations suggest that SPMs also have the potential to be used as a therapeutic aid when inflammation is established.
- Published
- 2022
- Full Text
- View/download PDF